How many clinical trials are studying YL201?

3 recruiting trials in our tracked data involve YL201.

What conditions is YL201 being studied for?

In our tracked recruiting trials, YL201 is being studied in trials for Lung cancer, Advanced Solid Tumors, Non Small Cell Lung Cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 2 Phase 2 2 Phase 3 1

Condition	Trials
Lung cancer · YL201 for Lung cancer	3
Advanced Solid Tumors	1
Non Small Cell Lung Cancer	1
SCLC, Extensive Stage	1
Small Cell Lung Cancer	1
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma	1

A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
NCT07208773 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
NCT07407933 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 22 locations
A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer
NCT07739758 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations